Question 1

What is Sunshine Biopharma?

Accepted Answer

Sunshine Biopharma is a Company.

Question 2

How often does Sunshine Biopharma appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 19 articles.

Question 3

When was Sunshine Biopharma first tracked by Ergen?

Accepted Answer

First tracked on May 18, 2026.

Question 4

When was Sunshine Biopharma last mentioned in news?

Accepted Answer

Last active on Jun 25, 2026.

Question 5

What is Sunshine Biopharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 53 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Sunshine Biopharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Sunshine Biopharma?

Accepted Answer

Sunshine Biopharma $6M Public Offering (May 18, 2026, 7 articles).

Question 8

Who is Sunshine Biopharma most connected to?

Accepted Answer

Top relationships: Steve N. Slilaty, Steve N. Slilaty (ceo), Canada.

Question 9

How did the "Sunshine Biopharma $6M Public Offering" event impact Sunshine Biopharma?

Accepted Answer

Sunshine Biopharma successfully closed a public offering, raising $6 million in gross proceeds with potential for an additional $12 million from warrant exercises, which will be used for general corporate purposes and working capital. This financing is substantial relative to its market capitalization and addresses its negative free cash flow.

Question 10

How did the "Sunshine Biopharma's Rivaroxaban Approved in Canada" event impact Sunshine Biopharma?

Accepted Answer

Sunshine Biopharma received approval for its generic Rivaroxaban tablets in Canada, expanding its portfolio of anticoagulant drugs and strengthening its position in the generics market.

Question 11

How did the "Sunshine Biopharma Anastrozole Canadian Approval" event impact Sunshine Biopharma?

Accepted Answer

Sunshine Biopharma received Canadian regulatory approval for its generic Anastrozole tablets, expanding its portfolio in breast cancer therapy and strengthening its position in the generics market. This approval is expected to contribute to its financial growth.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.